Concepedia
Statistics
Publications
17
Citations
1.6K
H-Index
15
Active since
1999
Affiliations
GlaxoSmithKline (United Kingdom)(Current)
University of Oxford
Victor Chang Cardiac Research Institute
UNSW Sydney
AstraZeneca (United Kingdom)
Yi Cui is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, pharmacology, and cell biology.
Top concepts
MedicinePhysiologyCell BiologyPharmacologyCardiologyIon ChannelsCell PhysiologyPharmacotherapyElectrophysiologyCardiovascular Pharmacology
Publications per year
1999–2024
A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria
Margaret A. Phillips, Julie Lotharius, Kennan C. Marsh et al. · Science Translational Medicine · 2015 · 367 citations
Simulation of multiple ion channel block provides improved early prediction of compounds’ clinical torsadogenic risk
Gary R. Mirams, Yi Cui, Anna Sher et al. · Cardiovascular Research · 2011 · 326 citations · Full text
Comparison of Electrophysiological Data From Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes to Functional Preclinical Safety Assays
Kate Harris, Mike Aylott, Yi Cui et al. · Toxicological Sciences · 2013 · 224 citations · Full text
Cardiac Muscle, Heart Failure, Ipsc-cms Offer +24
Prediction of Thorough QT study results using action potential simulations based on ion channel screens
Gary R. Mirams, Mark Davies, Stephen Brough et al. · Journal of Pharmacological and Toxicological Methods · 2014 · 96 citations · Full text
Variability in high-throughput ion-channel screening data and consequences for cardiac safety assessment
Ryan C. Elkins, Mark Davies, Stephen Brough et al. · Journal of Pharmacological and Toxicological Methods · 2013 · 91 citations · Full text
1–5 of 17